🚨 Coming Soon: We're publishing a major review on Long COVID and a comprehensive roadmap for policy and research priorities. 🗓️ Release Date: Friday, August 9, 5:00 AM ET 📣 Journalists who are interested in covering this, please contact us via email.

🕸️👀 Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression academic.oup.com/rheumatology/a…

What did we #learn after #sequencing #5million #Tcells #scRNA and #TCRseq with @lisa_wagar Andreas Tiffeau-Mayer Suhas Sureshchandra and funding agency Wellcome Leap STLChildrensHospital -Tissue determinants of the human T cell receptor repertoire. biorxiv.org/content/10.110…

Finally out: Characterizing T cell specific responses to vaccine and infection in HLA-DPB1*04-restricted patients across 4 time points. Thank you Philip Mudd and Ali Ellebedy for inviting me into this amazing data set. Paper: nature.com/articles/s4159…

FINALLLY. (Warning, this is a long thread.) It has been a long battle. My current R01 was about to end in November this year. I might have needed to close my lab by next Spring. I truly believed in my projects, but without funding, I could not continue. >>>

Pls spread the word — we need #SLE pts to help with this study! Pls retweet this CreakyJoints.org Lupus Research Lupus Foundation of America Jinoos Yazdany Alfred Kim (moving to Bluesky as alhkim) Dr. Rachel Tate Dr. John Cush Amanda G

In the African diaspora, SLE patients experience unacceptable outcomes. We discuss biologic and social vulnerability, and the legacies of colonialism and chattel slavery haunt patients. So proud of our review! Out now Dzifa Dey Dr SolaAyan frontiersin.org/journals/genet…

I am not afraid! But the post below is NOT ok. Someone who has 90 k followers is calling for my execution. I reported it, but it has not been removed yet. It has been there for 13 hours......This is NOT ok.

🚨NEW Publication in ACR_Journals🚨 with Dr. Edith & team! Limited #HealthLiteracy in pts w/ SLE was associated with worse outcomes: • ↓self-efficacy, pt activation, QOL • worse physician/pt communication • ↑disease activity (SLAQ), ↑damage acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

Wait a minute.

My presentation on post-transplant TMA. This thread is full of theory, which has been simmering in my head over the last decade. Our general view of conventional TMA is too narrow. Only a small subset of patients present acutely / catastrophically

Our latest study investigating risk factors for RA-ILD subtypes, led by Dr Gregory McDermott We systematically identified/subtyped all RA-ILD cases and RA-noILD controls in the Brigham and Women's Hospital RA Sequential Study and Mass General Brigham Biobank (n=3328) acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

🚨 Positive Phase III results for obinutuzumab in lupus nephritis!🚨 ✅ Higher CRR at 76 weeks with obinutuzumab + standard therapy vs. standard therapy alone. ✅ Safety profile; no new signals. Reduced steroid use & improved proteinuria. #Lupus roche.com/media/releases…

OUCH! This one hits hard!

#HCQbrigade

These data suggest that ANAmay/could be physiologic and part our autoimmune network- it also may inform why ANA but not Lupus (in most studies)is common s/p #covid Prof. Akiko Iwasaki. Ruslan Medzhitov (Bxcells?) Casanova Lab Jeffrey Sparks MD MMSc Alfred Kim (moving to Bluesky as alhkim) Mike Putman

The real implications of this impressive work is to why we make these autoAbs? This supports a physiological role Casanova Lab Transient anti-IFN autoantibodies in the airways are associated with recovery from COVID-19 | Science Translational Medicine science.org/doi/10.1126/sc…

Greeted by curse words from Alfred Kim (moving to Bluesky as alhkim) #ACR24

Original post: x.com/randomherowx/s…